R1 Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia (NCT06712654) | R1 Therapeutics | 2026-06-01 |
Track R1 Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.